| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients
|
Acevedo, Francisco
|
|
|
199 |
2 |
p. 363-370
|
artikel
|
| 2 |
Aspirin use is associated with improvement in distant metastases outcome in patients with residual disease after neoadjuvant chemotherapy
|
Johns, Christopher
|
|
|
199 |
2 |
p. 381-387
|
artikel
|
| 3 |
Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial
|
Parker, Barbara A.
|
|
|
199 |
2 |
p. 281-291
|
artikel
|
| 4 |
Bridging pre-surgical endocrine therapy for breast cancer during the COVID-19 pandemic: outcomes from the B-MaP-C study
|
Dave, Rajiv V.
|
|
|
199 |
2 |
p. 265-279
|
artikel
|
| 5 |
Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
|
Godina, Christopher
|
|
|
199 |
2 |
p. 335-347
|
artikel
|
| 6 |
Cholesterol and breast cancer risk: a cohort study using health insurance claims and health checkup databases
|
Narii, Nobuhiro
|
|
|
199 |
2 |
p. 315-322
|
artikel
|
| 7 |
Contrast enhanced mammography in breast cancer surveillance
|
Elder, Kenneth
|
|
|
199 |
2 |
p. 221-230
|
artikel
|
| 8 |
Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologists
|
Sars, Carl
|
|
|
199 |
2 |
p. 293-304
|
artikel
|
| 9 |
Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisis
|
Cheng, Joyce M.
|
|
|
199 |
2 |
p. 389-397
|
artikel
|
| 10 |
Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial)
|
Watanabe, Kenichi
|
|
|
199 |
2 |
p. 253-263
|
artikel
|
| 11 |
HER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series
|
Rothschild, Harriet T.
|
|
|
199 |
2 |
p. 349-354
|
artikel
|
| 12 |
Hypertensive conditions of pregnancy, preterm birth, and premenopausal breast cancer risk: a premenopausal breast cancer collaborative group analysis
|
Nichols, Hazel B.
|
|
|
199 |
2 |
p. 323-334
|
artikel
|
| 13 |
Impact of diabetes on surgery and radiotherapy for breast cancer
|
Lawrenson, Ross
|
|
|
199 |
2 |
p. 305-314
|
artikel
|
| 14 |
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41
|
Rastogi, Priya
|
|
|
199 |
2 |
p. 243-252
|
artikel
|
| 15 |
Metaplastic carcinoma of the breast: matched cohort analysis of recurrence and survival
|
Narayan, Priyanka
|
|
|
199 |
2 |
p. 355-361
|
artikel
|
| 16 |
Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials
|
Rassy, Elie
|
|
|
199 |
2 |
p. 371-379
|
artikel
|
| 17 |
Pharmacogenetics: uncovering the complex relationship between HIV and non-adherence among South African breast cancer patients treated with tamoxifen
|
Nthontho, Keneuoe C.
|
|
|
199 |
2 |
p. 399-400
|
artikel
|
| 18 |
Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy
|
Iwata, Hiroji
|
|
|
199 |
2 |
p. 231-241
|
artikel
|
| 19 |
Positive surgical margins after breast-conserving surgery for ductal carcinoma in-situ: does histologic grade or estrogen receptor status matter?
|
Fauveau, Lindsey R.
|
|
|
199 |
2 |
p. 215-220
|
artikel
|
| 20 |
Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics
|
Sayed, Shahin
|
|
|
199 |
2 |
p. 401-413
|
artikel
|
Tijdschrift beschrijving